Ifebemtinib is an orally bioavailable inhibitor of focal adhesion kinase (FAK/PTK2), a non-receptor cytoplasmic tyrosine kinase. It exhibits antineoplastic activity by competitively binding to ATP and blocking PTK2-mediated signaling, thereby inhibiting tumor cell migration, proliferation, invasion, and survival.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Ifebemtinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Gadodiamide hydrate
pharmaceutical raw material
Balovaptan
pharmaceutical raw material
N-Desmethyl Alosetron
pharmaceutical raw material
Alosetron hydrochloride
pharmaceutical raw material
The international HS code for Ifebemtinib (CAS 1227948-82-4) is 2933.79.
2933.79
2933 79 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-fluoro-5-methoxy-4-[[4-[(2-methyl-3-oxo-1H-isoindol-4-yl)oxy]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-(1-methylpiperidin-4-yl)benzamide
ULMMVBPTWVRPSI-UHFFFAOYSA-N
CN1CCC(CC1)NC(=O)C2=CC(=C(C=C2F)NC3=NC=C(C(=N3)OC4=CC=CC5=C4C(=O)N(C5)C)C(F)(F)F)OC
Sourcing Ifebemtinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.